Sri Pharmaceuticals And Research Center Profile
Key Indicators
- Authorised Capital ₹ 1.30 Cr
- Paid Up Capital ₹ 1.21 Cr
- Company Age 6 Year, 2 Days
- Open Charges ₹ 3.87 Cr
About Sri Pharmaceuticals And Research Center
Sri Pharmaceuticals And Research Center Private Limited (SPARCPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 February 2019 (Six years 2 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.30 Cr and a paid-up capital of Rs 1.21 Cr.
The company currently has active open charges totaling ₹3.87 Cr.
Kruti Rao and Himalay Rao serve as directors at the Company.
Company Details
-
Location
Gandhi Nagar, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74995GJ2019PTC106495
-
Company No.
106495
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Feb 2019
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sri Pharmaceuticals And Research Center?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kruti Rao
|
Director | 08-Feb-2019 | Current |
|
Himalay Rao
|
Director | 08-Feb-2019 | Current |
Financial Performance of Sri Pharmaceuticals And Research Center.
Enhance accessibility to Sri Pharmaceuticals And Research Center's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Pharmaceuticals And Research Center?
Unlock access to Sri Pharmaceuticals And Research Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Amirati Ventures Private LimitedKruti Rao and Himalay Rao are mutual person
-
Harshal Steel Private Limited
Himalay Rao is a mutual person
Charges (Loans)
₹3.87 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 3.87 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2020 | Others | ₹3.87 Cr | Open |
How Many Employees Work at Sri Pharmaceuticals And Research Center?
Unlock and access historical data on people associated with Sri Pharmaceuticals And Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Pharmaceuticals And Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Pharmaceuticals And Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.